
Leading Innovation in Oncology
​
Areva™ specializes in delivering high-quality oncology injectables that go a step beyond standard generics.
​
We are developing a wide variety of products that address the needs of traditional chemotherapy, ensuring that patients have greater access to affordable treatment.
​
Addressing Critical Drug Shortages
​
Areva™ is positioned to address critical drug shortages while building long-term relationships in the pharmaceutical market.
Oncology Expertise
​
Specializing in high-quality oncology injectables
Quality Assured
​
Products that go beyond standard generics
Safety First
​
Meeting the highest safety standards in pharmaceutical production
Patient Access
​
Ensuring greater access to affordable cancer treatment through our ArevaCares Program
Our Product Portfolio
Comprehensive oncology solutions designed to provide accessible, high-quality treatment options for patients worldwide
Oncology Injectables
​
High-quality injectable chemotherapy solutions manufactured under stringent safety protocols
Specialty Formulations
​
Innovative pharmaceutical formulations addressing specific oncology treatment needs
Our Products
High-quality injectable pharmaceutical solutions for oncology and supportive care
Injectable Products
Fludarabine Phosphate Injection
​
​50mg/2mL
Chronic Lymphocytic Leukemia (CLL), CART Therapy
Caspofungin Acetate Injectable LYO
​
50mg & 70mg
Invasive Fungal Infections
Bupivacaine HCL Injection
​
2.5mg/mL, 5mg/mL
Local Anesthesia
Terbutaline Injectable
​
1mg/mL
B2 Agonist, Bronchodilator Therapy
Furosemide Injection
​
​20mg/2mL, 40mg/4mL, 100mg/10mL
Loop Diuretic
Verapamil HCL Injection
​
​2.5mg, 5mg
Cardiovascular Support
Pamidronate Disodium Injection LYO
​
30mg, 60mg, 90mg
Hypercalcemia & Bone Metastases
Product Pipeline
Advancing oncology care through continuous innovation and development of high-quality pharmaceutical solutions

Manufacturing Excellence
Given the high degree of toxicity in the production process, producing high-quality, safe oncology injectables is a challenging task.
Our Commitment
​
Areva™ has more than met this challenge by committing significant resources towards manufacturing facilities that are the most advanced in the world.
​
​
State-of-the-art manufacturing facilities
​
Advanced technology for high-toxicity production
​
World-class quality control systems
​
ISO-certified production processes
​
Stringent safety protocols
​
Continuous innovation and improvement

15 PLUS
YEARS OF EXPERIENCE IN INJECTABLE MANUFACTURING
Leadership Team
Our experienced leadership team brings decades of pharmaceutical industry expertise to advance oncology care and address critical drug shortages.
Victor Swaminathan
RPh
CEO
Scott Cormiea
MBA
Chief Operating Officer
Mark Windley​
Chief Commercial Officer
Jim Eveslage
Chief Financial Officer
Dr. Sekhar Ayappanee
PhD
Chief Scientific Officer
Get in Touch
Have questions about our products or services? We're here to help.
7112 Areva Drive NE Georgetown , IN 47122
Helpful Resources
Our Partners
